Findings

What do systematic reviews say?

8 questions · 8 findings · 3 reviews · Incontinence · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 62.5%GRADE not reported 0 · 0%Very low 1 · 12.5%Low 1 · 12.5%Moderate 1 · 12.5%High 0 · 0%

PFMT added to drug therapy vs drug therapy alone

General health status evaluation e.g. Short Form (SF)‐36 ‐ not reported · women with urinary incontinence

The review found no eligible studies for this question.

1 finding from 1 review

Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary… 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs pelvic floor muscle training (PFMT)

Generic quality of life measures · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs devices such

Generic quality of life measures · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs surgery

Generic quality of life measures · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs no treatment or placebo

Generic quality of life measures · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen vs placebo or no treatment

Incontinence not improved (generic inverse variance) (women's observations) ‐ Systemic administration (any incontinence) · patients with urinary incontinence in post‐menopausal women

Oestrogen may leads to higher incontinence not improved (generic inverse variance) (women's… compared with placebo or no treatment (low certainty).

1 finding from 1 review

Oestrogen therapy for urinary incontinence in post‐menopausal women 2012 · Cochrane Headline outcomes only
RR 1.32 [1.17, 1.48]
6 studies · 6151 participants
Low

Oestrogen + other treatments vs placebo

Incontinence not improved (generic inverse variance) (women's observation) ‐ oestrogen + other treatments versus placebo · patients with urinary incontinence in post‐menopausal women

Oestrogen + other treatments probably leads to higher incontinence not improved (generic inverse variance) (women's… compared with placebo (moderate certainty).

1 finding from 1 review

Oestrogen therapy for urinary incontinence in post‐menopausal women 2012 · Cochrane Headline outcomes only
RR 1.11 [1.04, 1.18]
3 studies · 10635 participants
Moderate

Oestrogen vs placebo or no treatment

Incontinence not improved (generic inverse variance) (women's observations) ‐ Local administration (any incontinence) · patients with urinary incontinence in post‐menopausal women

It is very uncertain whether oestrogen changes incontinence not improved (generic inverse variance) (women's… compared with placebo or no treatment (very low certainty).

1 finding from 1 review

Oestrogen therapy for urinary incontinence in post‐menopausal women 2012 · Cochrane Headline outcomes only
RR 0.74 [0.64, 0.86]
4 studies · 213 participants
Very low